The downregulation of CDKN1B found in prostate lesions in Men1 mutant mice suggests the in vivo importance of CDKN1B inactivation in the tumorigenesis related to Men1 inactivation, similar to observations in other mouse Men1 tumour models [12,37-39]. This evidence concerns the gene CDKN1B and neoplasm.